Xeris Biopharma (NASDAQ: XERS) net income
Xeris Biopharma reported a net profit of $0.6m for fiscal 2025; in fiscal 2024 it reported a net loss of $54.8m. Its net margin was 0.2%. Earnings per share were $0.00.
Fiscal 2025 is the highest of the 6 fiscal years on record for Xeris Biopharma. It reported a loss in 5 of those 6 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $0.6m | — | 0.2% | $0.00 |
| 2024 | −$54.8m | — | −27.0% | −$0.37 |
| 2023 | −$62.3m | — | −38.0% | −$0.45 |
| 2022 | −$94.7m | — | −85.9% | −$0.70 |
| 2021 | −$122.7m | — | −247.5% | −$1.55 |
| 2020 | −$91.1m | — | −446.0% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Xeris Biopharma net income compared with its sector
By net income for its latest fiscal year, Xeris Biopharma ranks 172nd of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Xeris Biopharma, 0.2%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 170th | Warby Parker | $1.6m | 0.2% |
| 171st | ICU Medical | $0.7m | 0.0% |
| 172nd | Xeris Biopharma | $0.6m | 0.2% |
| 173rd | Alignment Healthcare | −$0.7m | −0.0% |
| 174th | Certara | −$1.6m | −0.4% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Xeris Biopharma
- How much did Xeris Biopharma earn in fiscal 2025?
- Xeris Biopharma reported a net profit of $0.6m for fiscal 2025. In fiscal 2024 it reported a net loss of $54.8m.
- What are the earnings per share of Xeris Biopharma?
- They were $0.00 in fiscal 2025, compared with −$0.37 in fiscal 2024.
- What is the net margin of Xeris Biopharma?
- In fiscal 2025 its net profit was 0.2% of its revenue.
- What was the most profitable year for Xeris Biopharma?
- Of its last 6 fiscal years, fiscal 2025, with $0.6m.
- Where does Xeris Biopharma rank in its sector by net income?
- It ranks 172nd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Xeris Biopharma come from?
- From the annual report (Form 10-K) that Xeris Biopharma files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Xeris Biopharma files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on Xeris Biopharma: the Xeris Biopharma page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.